OC
DBD

Oppenheimer & Co’s Diebold Nixdorf Incorporated DBD Stock Holding History

Oppenheimer & Co’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,906
Closed -$165K – 1407
2019
Q1 		$165K Buy
14,906
+1,000
+7% +$6.99K ﹤0.01% 1258
2018
Q4 		$35K Sell
13,906
-17,197
-55% -$61.7K ﹤0.01% 1220
2018
Q3 		$139K Sell
31,103
-5,921
-16% -$43.2K ﹤0.01% 1286
2018
Q2 		$442K Sell
37,024
-1,300
-3% -$17.4K 0.01% 915
2018
Q1 		$590K Buy
38,324
+2,449
+7% +$40.9K 0.02% 792
2017
Q4 		$587K Sell
35,875
-2,397
-6% -$46.3K 0.02% 804
2017
Q3 		$874K Buy
38,272
+6,976
+22% +$149K 0.02% 656
2017
Q2 		$876K Sell
31,296
-3,199
-9% -$88.5K 0.02% 642
2017
Q1 		$1.06M Sell
34,495
-456
-1% -$12.9K 0.03% 569
2016
Q4 		$879K Buy
34,951
+1,907
+6% +$45K 0.03% 603
2016
Q3 		$820K Buy
33,044
+1,451
+5% +$38.5K 0.02% 634
2016
Q2 		$785K Buy
31,593
+1,362
+5% +$35.1K 0.02% 626
2016
Q1 		$875K Sell
30,231
-4,499
-13% -$118K 0.03% 577
2015
Q4 		$1.04M Hold
34,730
– – 0.03% 538
2015
Q3 		$1.03M Sell
34,730
-1,000
-3% -$32.5K 0.03% 571
2015
Q2 		$1.25M Buy
35,730
+900
+3% +$31.7K 0.03% 557
2015
Q1 		$1.24M Sell
34,830
-3,698
-10% -$125K 0.03% 568
2014
Q4 		$1.33M Buy
38,528
+767
+2% +$27K 0.04% 523
2014
Q3 		$1.33M Buy
37,761
+5,000
+15% +$189K 0.04% 513
2014
Q2 		$1.32M Buy
32,761
+500
+2% +$19.2K 0.04% 517
2014
Q1 		$1.29M Buy
32,261
+26,121
+425% +$940K 0.04% 512
2013
Q4 		$203K Buy
+6,140
New +$191K 0.01% 1206

Other funds holding DBD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Oppenheimer & Co's DBD Position: Q2 2019 in Review

Oppenheimer & Co sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2019, closing a stake of 14,906 shares — an estimated $165K sold.

Oppenheimer & Co first reported a position in DBD in Q4 2013 and held it in 22 quarters. The position peaked at $1.33M in Q4 2014. 198 funds tracked by Wall St. Rank hold DBD as of Q2 2019.

  • Oppenheimer & Co reported no remaining Diebold Nixdorf Incorporated position as of Q2 2019 after selling out during the quarter.
  • Oppenheimer & Co sold 14,906 Diebold Nixdorf Incorporated shares in Q2 2019, an estimated $165K.
  • Oppenheimer & Co first reported a position in Diebold Nixdorf Incorporated in Q4 2013 and held it in 22 quarters.
  • Oppenheimer & Co's Diebold Nixdorf Incorporated position peaked at $1.33M in Q4 2014.
  • 198 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2019.

Based on Oppenheimer & Co's 13F filing for Q2 2019, filed 9 Aug 2019.